USP4 Promotes the Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma by Targeting TAK1

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2023 Nov 10

PMID 37949874

Authors

Hongdian Zhang

Youming Han

Wanyi Xiao

Yongyin Gao

Zhilin Sui

Peng Ren

Fanbiao Meng

Peng Tang

Zhentao Yu

Affiliations

Soon will be listed here.

Abstract

Ubiquitin-specific protease 4 (USP4) represents a potential oncogene involved in various human cancers. Nevertheless, the biological roles and precise mechanism of USP4 in esophageal squamous cell carcinoma (ESCC) progression are not understood. Here, USP4 expression was found to be markedly upregulated in ESCC tumor tissues and cells. Loss- and gain-of-function assays suggested that USP4 silencing inhibited ESCC cell proliferation, migration, and invasion, while USP4 overexpression promoted these behaviors. Consistently, USP4 silencing repressed tumor growth and metastasis in an ESCC nude mouse model in vivo. As a target molecule of USP4, transforming growth factor-β-activated kinase 1 (TAK1) also showed high expression in ESCC. Moreover, we observed that USP4 specifically interacted with TAK1 and stabilized TAK1 protein levels via deubiquitination in ESCC cells. Importantly, USP4 promotes ESCC proliferation, migration, and invasion via the MEK/ERK signaling pathway and can be inhibited by U0126. Neutral red (NR), an inhibitor of USP4 can suppress ESCC progression in vitro and in vivo. Overall, this study revealed that USP4/TAK1 plays crucial roles in ESCC progression by modulating proliferation, migration, and invasion, and USP4 might be a potential therapeutic target in ESCC.

Citing Articles

A novel mechanism in regulating drug sensitivity, growth, and apoptosis of bortezomib-resistant multiple myeloma cells: the USP4/KLF2/HMGA2 cascade.

Liu Z, Li X, He Y, Xie F, Zhang Y, Huang M J Orthop Surg Res. 2025; 20(1):220.

PMID: 40022160 PMC: 11871775. DOI: 10.1186/s13018-025-05537-1.

USP4-mediated CENPF deubiquitylation regulated tumor metastasis in colorectal cancer.

Xie Z, Lin H, Wu Y, Yu Y, Liu X, Zheng Y Cell Death Dis. 2025; 16(1):81.

PMID: 39922805 PMC: 11807140. DOI: 10.1038/s41419-025-07424-3.

A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation.

Li F, Zhou Y, Lin X, Zhang Y, Hu Q, Zhao E J Transl Med. 2025; 23(1):114.

PMID: 39856683 PMC: 11762077. DOI: 10.1186/s12967-024-06001-0.

Deubiquitinases as novel therapeutic targets for diseases.

Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W MedComm (2020). 2024; 5(12):e70036.

PMID: 39678489 PMC: 11645450. DOI: 10.1002/mco2.70036.

USP4 promotes PTC progression by stabilizing LDHA and activating the MAPK and AKT signaling pathway.

Hu C, Zhang W, Jia Y, Zhao J, Chen Q, Hao C Aging (Albany NY). 2024; 16(19):12850-12865.

PMID: 39393052 PMC: 11501377. DOI: 10.18632/aging.206108.

References

Zhang H, Wu X, Sui Z, Ma Z, Gong L, Meng B . High-mobility group AT-hook 2 promotes growth and metastasis and is regulated by miR-204-5p in oesophageal squamous cell carcinoma. Eur J Clin Invest. 2021; 51(8):e13563. DOI: 10.1111/eci.13563. View

Das T, Lee E, You H, Kim E, Song E . USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1. Cell Death Discov. 2022; 8(1):24. PMC: 8758713. DOI: 10.1038/s41420-022-00820-0. View

Li C, Zhao S, Zheng Y, Han Y, Chen X, Cheng Z . Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1). Eur J Cancer. 2020; 144:232-241. DOI: 10.1016/j.ejca.2020.11.039. View

Piro G, Giacopuzzi S, Bencivenga M, Carbone C, Verlato G, Frizziero M . TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients. Br J Cancer. 2015; 113(6):878-85. PMC: 4578082. DOI: 10.1038/bjc.2015.283. View

Zhou Y, Zhang Y, Lian X, Li F, Wang C, Zhu F . Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Res. 2021; 50(D1):D1398-D1407. PMC: 8728281. DOI: 10.1093/nar/gkab953. View

Tang Q, Chen Z, Xie J, Mo C, Lu J, Zhang Q . Transcriptome Analysis and Single-Cell Sequencing Analysis Constructed the Ubiquitination-Related Signature in Glioma and Identified USP4 as a Novel Biomarker. Front Immunol. 2022; 13:915709. PMC: 9238360. DOI: 10.3389/fimmu.2022.915709. View

Gao Y, Guan L, Jia R, Xiao W, Han Y, Li Y . High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis. BMC Cancer. 2023; 23(1):417. PMC: 10169376. DOI: 10.1186/s12885-023-10872-9. View

Chen Z, Han S, Huang W, Wu J, Liu Y, Cai S . MicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin-Yang 1. Biochem Biophys Res Commun. 2016; 479(3):482-488. DOI: 10.1016/j.bbrc.2016.09.089. View

Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z . Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial. JAMA Surg. 2021; 156(8):721-729. PMC: 8223138. DOI: 10.1001/jamasurg.2021.2373. View

10.

Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska B, Mickanin C . USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol. 2012; 14(7):717-26. DOI: 10.1038/ncb2522. View

11.

Peng R, Chen Y, Wei L, Li G, Feng D, Liu S . Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer. Gastric Cancer. 2020; 23(6):988-1002. DOI: 10.1007/s10120-020-01088-y. View

12.

Santoro R, Carbone C, Piro G, Chiao P, Melisi D . TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy. Drug Resist Updat. 2017; 33-35:36-42. DOI: 10.1016/j.drup.2017.10.004. View

13.

Morgan E, Soerjomataram I, Rumgay H, Coleman H, Thrift A, Vignat J . The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022; 163(3):649-658.e2. DOI: 10.1053/j.gastro.2022.05.054. View

14.

Kim M, Min Y, Jeong S, Son J, Kim J, Lee J . USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction. Cell Death Dis. 2022; 13(4):348. PMC: 9010460. DOI: 10.1038/s41419-022-04808-7. View

15.

Hu B, Zhang D, Zhao K, Wang Y, Pei L, Fu Q . Spotlight on USP4: Structure, Function, and Regulation. Front Cell Dev Biol. 2021; 9:595159. PMC: 7935551. DOI: 10.3389/fcell.2021.595159. View

16.

Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J . USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target. Cancer Cell Int. 2020; 20:298. PMC: 7350758. DOI: 10.1186/s12935-020-01391-9. View

17.

He S, Xu J, Liu X, Zhen Y . Advances and challenges in the treatment of esophageal cancer. Acta Pharm Sin B. 2021; 11(11):3379-3392. PMC: 8642427. DOI: 10.1016/j.apsb.2021.03.008. View

18.

Fan Y, Yu Y, Mao R, Tan X, Xu G, Zhang H . USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Cell Death Differ. 2011; 18(10):1547-60. PMC: 3136563. DOI: 10.1038/cdd.2011.11. View

19.

Yao R, Pu J, Fan R, Zhu W, Ding X, Shen X . Ubiquitin-specific protease 4 improves the prognosis of the patients in esophageal cancer. Cancer Biomark. 2017; 20(3):317-323. DOI: 10.3233/CBM-170308. View

20.

Li R, Shang R, Li S, Ren Y, Shen L, Yang L . LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition. Environ Toxicol. 2022; 37(10):2540-2551. DOI: 10.1002/tox.23617. View